ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

6 links0 made here, not in the record12 judgments2 judges (the rules as one: Rule based)2 record changes seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.govReplaced, or read an older version
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT06975111Focusing on the MenopausalTransition to ImproveMid-Life Women's HealthUniversity of Colorado, DenverPhase 2/Phase 3 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Nov 3 · ClinicalTrials.gov record · Version of 2026-11-03Nov 4 · ClinicalTrials.gov record · Version of 2026-11-04Version of 2026-11-04CONDITIONSHot FlashesNo longer in the registry's filing›As of now · Rule based · Main conditionMain conditionDRUGSMetforminIntervention entry›Nov 1 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorSemaglutideIntervention entry›Nov 1 · Claude Opus 5.5 · TestedNov 1 · Claude Opus 5.5 · TestedNov 18 · Rule based · ComparatorTestedINT007003Entry “Anti-hypertensives”, read by o…›Nov 1 · Claude Opus 5.5 · ComparatorNov 18 · Rule based · ComparatorComparatorFezolinetantIntervention entry›Nov 1 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTestedINT010015Entry “Hormonal therapy”, read by our…›Nov 1 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Metformin

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Metformin”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Comparator
Comparator · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 1MetforminClaude Opus 5.5ComparatorCurrent
Nov 1SemaglutideClaude Opus 5.5TestedReplaced
Nov 1INT007003Claude Opus 5.5ComparatorCurrent
Nov 1FezolinetantClaude Opus 5.5TestedCurrent
Nov 1INT010015Claude Opus 5.5TestedCurrent
Nov 1SemaglutideClaude Opus 5.5TestedCurrent
Nov 3The record itselfClinicalTrials.gov recordVersion of 2026-11-03Record change
Nov 4The record itselfClinicalTrials.gov recordVersion of 2026-11-04Record change
Nov 18MetforminRule based · role ruleComparatorAgrees
Nov 18SemaglutideRule based · role ruleComparatorOverridden
Nov 18INT007003Rule based · role ruleComparatorAgrees
Nov 18FezolinetantRule based · role ruleTestedAgrees
Nov 18INT010015Rule based · role ruleTestedAgrees
As of nowHot FlashesRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.